Vijaya Chadaram

Randomized Multicenter Trial of Hyperthermic Isolated Limb Perfusion With Melphalan Alone Compared With Melphalan Plus Tumor Necrosis Factor: American College of Surgeons Oncology Group Trial Z0020

Wendy R. Cornett, Linda McCall, Rebecca P. Petersen et al. · Journal of Clinical Oncology · 2006 · 221 citations

A Randomized Phase II Study of Immunization With Dendritic Cells Modified With Poxvectors Encoding CEA and MUC1 Compared With the Same Poxvectors Plus GM-CSF for Resected Metastatic Colorectal Cancer

Michael A. Morse, Donna Niedzwiecki, John L. Marshall et al. · Annals of Surgery · 2013 · 139 citations · Full text

Phase II Trial of Dasatinib in Patients with Metastatic Breast Cancer Using Real-Time Pharmacodynamic Tissue Biomarkers of Src Inhibition to Escalate Dosing

Christina I. Herold, Vijaya Chadaram, Bercedis L. Peterson et al. · Clinical Cancer Research · 2011 · 79 citations · Full text

Adjuvant imatinib mesylate in patients with primary high risk gastrointestinal stromal tumor (GIST) following complete resection: Safety results from the U.S. Intergroup Phase II trial ACOSOG Z9000

Ronald P. DeMatteo, Cristina Antonescu, Vijaya Chadaram et al. · Journal of Clinical Oncology · 2005 · 72 citations

Surgical Oncology, Cancer Management, Gastroenterology +19

Survival rates among patients vaccinated following resection of colorectal cancer metastases in a phase II randomized study compared with contemporary controls.

Michael A. Morse, Donna Niedzwiecki, J. Marshall et al. · Journal of Clinical Oncology · 2011 · 12 citations

Surgical Oncology, Immunology, Immunoediting +24